Concepedia

Author

Patrick T. Bruck

Goethe University FrankfurtORCID

Also Known As

P Brück, P. Brück, Patrick Bruck, Patrick Brück, Patrick Brück, Patrick T Bruck, Patrick T. Bruck

90

Publications

2.1K

Citations

23

H-Index

40

Concepts

All Affiliations

Goethe University FrankfurtUniversity Hospital FrankfurtHarvard UniversityDana-Farber Cancer InstituteHeidelberg University
PT

About

Patrick T. Bruck is an author at Goethe University Frankfurt specializing in medicine, immunology, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

570

2

Engineering

1

1

40

3

Health Sciences

1

1

67

4

Biomedical Engineering

1

1

40

5

Blood Transplantation

1

1

228

Patrick T. Bruck

×

34

Publications

2K

Citations

23

H-Index

YearCitations

Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

Anna Pavlova, Lydia Wunderle, Johannes Oldenburg,

Blood

2007

249

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

Wolfgang Bethge, Jolanta Dengler, M Bornhäuser,

Leukemia

2012

228

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

Michael Stadler, Martin Bornhäuser, Gesine Bug,

Blood

2005

199

CYP2R1 (vitamin D 25‐hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans

Elizabeth Ramos‐Lopez, Patrick T. Bruck, Thomas Jansen,

Diabetes/Metabolism Research and Reviews

2007

163

Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.

Wolf‐Karsten Hofmann, Martina Komor, Urban Scheuring,

PubMed

2003

107

Glucocorticoid Hormone Stimulates Mitochondrial Biogenesis Specifically in Skeletal Muscle

Katharina Weber, Patrick T. Bruck, Zsuzsanna Mikes,

Endocrinology

2002

106

Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer

Sayeda Yasmin‐Karim, Patrick T. Bruck, Michèle Moreau,

Frontiers in Immunology

2018

84

Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs

Michael Dougan, Jessica R. Ingram, Hee‐Jin Jeong,

Cancer Immunology Research

2018

81

Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl–positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571)

Urban Scheuring, Patrick T. Bruck, Johannes Atta,

Blood

2002

75

Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia

Thoralf Lange, Sylvia Wystub, Jacqueline Maier,

Leukemia

2012

67

Page 1